The global market leader in polyisoprene rubber latex for medical-end markets, Cariflex has relocated its global headquarters (HQ) to Singapore. 

Previously located in the city centre, a fit-for-purpose office had been set up in 2020 after the establishment of Cariflex in Singapore as a wholly owned subsidiary of DL Chemical Co., Ltd (based in South Korea). The move signifies the strengthening of Cariflex's presence in Asia, and increased job opportunities locally. 

"The construction of our largest polyisoprene latex plant in Jurong Island, Singapore is progressing well.  The plant is expected to be operational by the second half of 2024, and it will create at least 80 permanent jobs in engineering, production, quality, supply chain, and other manufacturing support functions", said Prakash Kolluri, CEO of Cariflex.

DL Chemical Co., Ltd subsidiary companies, Kraton Polymers Singapore Pte. Ltd. and DL Chemical Co., Ltd Singapore Branch, will also be co-located in the same office, leveraging the business and site synergies.

Cariflex produces high value-added synthetic rubbers and latexes used for medical materials such as surgical gloves and rubber stoppers and seals for drug delivery devices.